Shimal Research Laboratories Limited - Due diligence report

A 360° intelligence report on Shimal Research Laboratories Limited: trust score, financial health, credit view, compliance, directors, growt…

2001-01-12 New Delhi, Delhi Under Process Of Striking Off Unlisted Active Non-Compliant
Share
Connect MCP
SR Shimal Research Laboratories Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Shimal Research Laboratories Limited — 360° Intelligence Report

Generated from MCA filings & public records
48/100
Trust Score
Caution Indicated

Shimal Research Laboratories Limited is assessed as Caution Indicated with a Trust Score of 48/100. Shimal Research Laboratories Limited is a public limited indian non-government company incorporated in 2001, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Shimal Research Laboratories Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Under Process Of Striking Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2018 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
PRADEEP KUMAR SHUKLA 01234567 Director 01/04/2018 6 yrs Approved
PRAKASH MISHRA 01234567 Director 01/04/2018 6 yrs Approved
SANJEEV KUMAR SINGHAL 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • PRADEEP KUMAR SHUKLA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Oscar Investments Limited
Subsidiaries
1
Group entities
1
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Fortis Clinical Research Limited Subsidiary Company 74.00%
Oscar Investments Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 55
Growth signals & trust indicators
Steady revenue growth: +1.42 over 1 year(s).
Latest year revenue grew 2.1x.
Operating for 25+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Under Process Of Striking Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence35/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment45/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view61/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
27 Sep 2018
Director ceased
PRADEEP KUMAR SHUKLA
Director ceased
PRAKASH MISHRA
Last AGM held
Annual general meeting
27 Aug 2018
Director appointed
PRAKASH MISHRA (Director)
Director ceased
JASBIR SINGH GREWAL
02 Apr 2018
Director appointed
PRADEEP KUMAR SHUKLA (Director)
31 Mar 2018
Latest balance sheet
Filed with ROC
27 Sep 2017
Director ceased
RAHUL RANJAN
27 Sep 2016
Director ceased
CHANDRA SHEKHAR JHA
18 Jun 2016
Director ceased
ANIL PANWAR
30 Sep 2014
Director ceased
HEMANT DHINGRA
10 Dec 2013
Director ceased
ANUJ CHOWDHRY
28 Nov 2011
Director appointed
SANJEEV KUMAR SINGHAL (Director)
Director ceased
SUNITA NAIDOO
Director ceased
MALVINDER MOHAN SINGH
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 1 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
We Cure Health And Safety Systems Private Limited U85100MH2010PTC198439 Mumbai, Maharashtra, India
Lily White Health Consortium Private Limited U85100KA2011PTC060098 Bangalore, Karnataka, India
India Social Responsibility Vision U91990GA2013NPL007245 Bardez, Goa, India
Sat Kaival Medical Research Foundation U85195GJ2013NPL074703 Anand, Gujarat, India
Laughter Yoga International Private Limited U74900MH2015PTC374419 Nashik, Maharashtra, India
Gsrb Foundation U93000DL2012NPL236890 New Delhi, Delhi, India
Vanashree Ayurved Private Limited U24233PN2005PTC020252 Pune, Maharashtra, India
Bhooshan Remedies Private Limited U24233UP2008PTC035108 Lucknow, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Shimal Research Laboratories Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Shimal Research Laboratories Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Shimal Research Laboratories Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Shimal Research Laboratories Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Shimal Research Laboratories Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Shimal Research Laboratories Limited an active company?

Shimal Research Laboratories Limited has MCA status “Under Process Of Striking Off” with a compliance score of 10/100 (Caution Indicated).

Is Shimal Research Laboratories Limited financially healthy?

Shimal Research Laboratories Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Shimal Research Laboratories Limited?

Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Shimal Research Laboratories Limited?

The ultimate holding entity is Oscar Investments Limited. 3 active director(s) are on record.

Does Shimal Research Laboratories Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Shimal Research Laboratories Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Shimal Research Laboratories Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.